InvestorsHub Logo
Followers 261
Posts 13808
Boards Moderated 0
Alias Born 04/12/2007

Re: kofikbaz post# 173

Tuesday, 10/10/2017 6:08:59 AM

Tuesday, October 10, 2017 6:08:59 AM

Post# of 282
R/S is not good for current shareholder, but many don't unterstand that dilution or R/S is a nessesary tool for early stage biotech companies. Guess it's going to dip after RS, than plan to enter
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TNDM News